购物车
- 全部删除
- 您的购物车当前为空
Z-FA-FMK 是一种广谱的卤代甲基酮抑制剂,可抑制冠状病毒蛋白酶3CL,Ki 为 25.7 μM。它可以不可逆地抑制半胱氨酸蛋白酶,也可以抑制效应半胱天冬酶。
为众多的药物研发团队赋能,
让新药发现更简单!
Z-FA-FMK 是一种广谱的卤代甲基酮抑制剂,可抑制冠状病毒蛋白酶3CL,Ki 为 25.7 μM。它可以不可逆地抑制半胱氨酸蛋白酶,也可以抑制效应半胱天冬酶。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 498 | 现货 | |
5 mg | ¥ 1,790 | 现货 | |
10 mg | ¥ 2,710 | 现货 | |
25 mg | ¥ 4,530 | 现货 | |
50 mg | ¥ 6,450 | 现货 | |
100 mg | ¥ 8,820 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,750 | 现货 |
产品描述 | Z-FA-FMK can irreversibly inhibit cysteine protease and also inhibit effector caspases. |
靶点活性 | 3CLpro (SARS Protease):25.7 μM (Ki) |
体外活性 | Z-FA-FMK可阻断重症综合性免疫缺陷小鼠体内Ras致癌肿瘤和宿主心脏组织的呼吸道病毒感染.在鼻内肺炎球菌感染的小鼠模型中,Z-FA-FMK可使肺和血液中肺炎球菌的生长显著增加. |
体内活性 | Z-FA-FMK可有效阻断体外实验中IL-2和分裂原诱导的T细胞增殖。通过成纤维细胞和破骨细胞,Z-FA-FMK可抑制纤维状胶原的降解。 Z-FA-FMK可抑制巨噬细胞中NF-κB依赖性基因的表达,从而抑制脂多糖诱导的细胞因子的产生。 |
细胞实验 | T cell proliferation following mitogen stimulation is determined using [3H]thymidine incorporation. In brief, PBMCs or purified T cells are seeded in a 96-well plate and stimulated with either PHA (5 μg/ml), costimulated with anti-CD3 mAb (5 μg/ml) and anti-CD28 mAb (2.5 μg/ml) or PMA plus ionomycin in the presence or absence of z-FA-FMK. The cells are cultured for 72 h with the last 16 h pulsed with [methyl-3H]thymidine (0.037 MBq). The cells are harvested onto glass fiber filter mats using a Tomtec automated multiwell harvester. (Only for Reference) |
分子量 | 386.42 |
分子式 | C21H23FN2O4 |
CAS No. | 197855-65-5 |
Smiles | CC(NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 71 mg/mL (183.7 mM) Ethanol: 32 mg/mL (82.8 mM) | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容